51 51 GEIGY (Lopressor 50 mg)
Generic Name: metoprolol
Pill with imprint 51 51 GEIGY is Pink, Elliptical/Oval and has been identified as Lopressor 50 mg. It is supplied by Novartis Pharmaceuticals.
Lopressor is used in the treatment of angina; angina pectoris prophylaxis; high blood pressure; heart attack; left ventricular dysfunction and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Lopressor 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 51 51 GEIGY


Lopressor
- Generic Name
- metoprolol
- Imprint
- 51 51 GEIGY
- Strength
- 50 mg
- Color
- Pink
- Size
- 13.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- Inactive Ingredients
-
microcrystalline cellulose,
silicon dioxide,
D&C Red No. 30,
lactose anhydrous,
magnesium stearate,
polyethylene glycol,
povidone,
1-propoxy-2-propanol,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00078-0458 (Discontinued) | Novartis Pharmaceuticals Corporation |
55289-0627 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
54868-0685 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Lopressor (metoprolol)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (15)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: cardioselective beta blockers
Patient resources
- Advanced Reading
- Lopressor Intravenous (Advanced Reading)
- Lopressor (Metoprolol Injection)
- Lopressor (Metoprolol Tablets)
- Other brands
- Toprol-XL, Kapspargo Sprinkle
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.